|
CAPR Capricor Therapeutics Inc 1133869 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-33,941,345.00 |
| Balance Sheet |
|
Current Assets
|
$283,088,809.00 |
|
Assets
|
$326,283,517.00 |
|
Current Liabilities
|
$33,637,289.00 |
|
Liabilities
|
$47,580,884.00 |
|
Equity
|
$278,702,633.00 |
|
Shares Out
|
57664673.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-29,254,891.00 |
|
Investing Cash Flow
|
$-154,641,596.00 |
| Market Analysis |
Market Cap
|
$241,614,979.87 |
|
Price
|
$3.89 |
|
BVPS
|
4.83 |
|
PB
|
0.87 |
|
EPS
|
-0.59 |
|
FCF
|
$-34,376,600.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.62 |
|
|
2026-05-12 |
-0.59 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.57 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.54 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CAPR documents filed with the SEC.
CAPR Filings
Clear
